-Homerun again! Genentech’s Herceptin effective in patients with HER2-positive stomach cancer. [FiercePharma]

-Uh-oh, Canada’s biotech companies are in BIG TROUBLE… [Ottawa Citizen]

-German-based InflaRx has received an undisclosed amount of funding from Affentranger Associates. InflaRx will use the funds to advance its anti-complement antibodies for sepsis. GOOD LUCK! [peHUB]

-Bring in the cash however you can, Pfizer trying to sell its animal health business. [WSJ]

Nothing else exciting worth noting today…slow

Related Posts